Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$144.95 - $152.29 $15,074 - $15,838
104 Added 21.67%
584 $88,000
Q2 2022

Aug 12, 2022

SELL
$83.14 - $145.99 $21,200 - $37,227
-255 Reduced 34.69%
480 $69,000
Q1 2022

May 12, 2022

SELL
$110.08 - $142.92 $25,538 - $33,157
-232 Reduced 23.99%
735 $87,000
Q4 2021

Feb 11, 2022

BUY
$99.73 - $148.48 $15,857 - $23,608
159 Added 19.68%
967 $133,000
Q3 2021

Nov 05, 2021

BUY
$98.85 - $138.91 $7,117 - $10,001
72 Added 9.78%
808 $112,000
Q2 2021

Aug 06, 2021

SELL
$65.78 - $105.02 $7,170 - $11,447
-109 Reduced 12.9%
736 $71,000
Q1 2021

May 07, 2021

SELL
$64.07 - $91.75 $53,242 - $76,244
-831 Reduced 49.58%
845 $57,000
Q4 2020

Feb 12, 2021

SELL
$65.07 - $98.24 $4,229 - $6,385
-65 Reduced 3.73%
1,676 $143,000
Q3 2020

Nov 06, 2020

BUY
$59.04 - $77.95 $1,535 - $2,026
26 Added 1.52%
1,741 $113,000
Q2 2020

Aug 07, 2020

BUY
$29.01 - $74.23 $48,968 - $125,300
1,688 Added 6251.85%
1,715 $125,000
Q1 2020

May 08, 2020

BUY
$27.51 - $57.29 $742 - $1,546
27 New
27 $0
Q4 2019

Feb 07, 2020

SELL
$40.86 - $57.65 $3,513 - $4,957
-86 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$37.38 - $49.47 $485 - $643
-13 Reduced 13.13%
86 $3,000
Q2 2019

Aug 09, 2019

BUY
$39.79 - $67.01 $3,939 - $6,633
99 New
99 $0
Q2 2018

Aug 10, 2018

SELL
$23.62 - $42.29 $614 - $1,099
-26 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$20.44 - $35.56 $40 - $71
2 Added 8.33%
26 $0
Q3 2017

Nov 13, 2017

BUY
$23.54 - $38.21 $564 - $917
24
24 $0

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.